Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Neuropeptide Y receptor Y4 (Y4R) is a member of the G protein-coupled receptor (GPCR) superfamily, specifically within the neuropeptide Y receptor family. It is primarily recognized for its high affinity to pancreatic polypeptide (PP), distinguishing it from other NPY receptors. It is involved in appetite regulation, energy homeostasis, and gastrointestinal motility. Targeting this receptor may offer new avenues for anti-obesity drugs or metabolic disorder interventions.
Gi/o protein coupling, inhibition of adenylyl cyclase, reduction in cAMP levels, downstream signaling events that mediate physiological effects
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuropeptide Y Receptor Y4 (Y4R).